Signaling pathways
- BA5692 PA-9Summary: PA-9 is a pituitary adenylate cyclase-activating polypeptide (PACAP) type I receptor antagonist.
- BA5693 ForopafantSummary: Foropafant (SR27417) is a potent, competitive, selective, orally available platelet-activating factor receptor antagonist.
- BA5694 KadsurenoneSummary: Kadsurenone is a lignan with platelet-activating factor-specific antagonistic activity.
- BA5695 TreprostinilSummary: Treprostinil is a highly effective agonist.
- BA5696 DG-041Summary: DG-041 is an effective, high affinity, selective antagonist.
- BA5697 AsapiprantSummary: Asapiprant is a potent and selective receptor antagonist.
- BA5698 RO1138452Summary: RO1138452 is a potent and selective prostacyclin receptor antagonist.
- BA5699 TravoprostSummary: Travoprost (Fluprostenolisopropylester), an isopropyl ester precursor, is a high-affinity, selective full prostaglandin receptor agonist.
- BA5700 OmidenepagSummary: Omidenepag (UR-7276) is the pharmacologically active form of OmidenepagIsopropyl, a selective non-prostaglandin receptor agonist with an EC of 1.1 nM.
- BA5701 NTP42Summary: NTP42 is a thromboxane receptor antagonist that antagonizes TP-mediated [Ca] circulation after stimulation of cells with the prostaglandin receptor (TP) agonist U46619 with an IC of 3.278 nM.